These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31895076)

  • 1. Risk factors and molecular characterization of penile cancer: impact on prognosis and potential targets for systemic therapy.
    Thomas A; Vanthoor J; Vos G; Tsaur I; Albersen M;
    Curr Opin Urol; 2020 Mar; 30(2):202-207. PubMed ID: 31895076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study.
    Necchi A; Lo Vullo S; Perrone F; Raggi D; Giannatempo P; Calareso G; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Togliardi E; Colecchia M; Busico A; Gloghini A; Testi A; Mariani L; Salvioni R
    BJU Int; 2018 Mar; 121(3):348-356. PubMed ID: 28921872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic mechanisms in penile carcinoma.
    Kuasne H; Marchi FA; Rogatto SR; de Syllos Cólus IM
    Int J Mol Sci; 2013 May; 14(6):10791-808. PubMed ID: 23702847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact.
    Kuasne H; Barros-Filho MC; Busso-Lopes A; Marchi FA; Pinheiro M; Muñoz JJ; Scapulatempo-Neto C; Faria EF; Guimarães GC; Lopes A; Trindade-Filho JC; Domingues MA; Drigo SA; Rogatto SR
    Oncotarget; 2017 Feb; 8(9):15294-15306. PubMed ID: 28122331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penile cancer: potential target for immunotherapy?
    Vanthoor J; Vos G; Albersen M
    World J Urol; 2021 May; 39(5):1405-1411. PubMed ID: 33145666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets.
    Chipollini J; Chaing S; Azizi M; Kidd LC; Kim P; Spiess PE
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28813024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penile Cancer-Derived Cells Molecularly Characterized as Models to Guide Targeted Therapies.
    Kuasne H; Canto LMD; Aagaard MM; Muñoz JJM; Jamblinne C; Marchi FA; Scapulatempo-Neto C; Faria EF; Lopes A; Carréno S; Rogatto SR
    Cells; 2021 Apr; 10(4):. PubMed ID: 33917394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus genotypes and P16INK4A expression in squamous penile carcinoma in Mexican patients.
    Martínez-Bailón C; Mantilla-Morales A; Méndez-Matías G; Alvarado-Cabrero I; Maldonado-Rodríguez R; Quintero-Becerra J; Arias-Flores R; Piña-Sánchez P
    BMC Infect Dis; 2019 Dec; 19(1):1068. PubMed ID: 31856740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic profiling reveals the pivotal role of hrHPV driving copy number and gene expression alterations, including mRNA downregulation of TP53 and RB1 in penile cancer.
    Macedo J; Silva E; Nogueira L; Coelho R; da Silva J; Dos Santos A; Teixeira-Júnior AA; Belfort M; Silva G; Khayat A; de Oliveira E; Dos Santos AP; Cavalli LR; Pereira SR
    Mol Carcinog; 2020 Jun; 59(6):604-617. PubMed ID: 32212199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics, trends, and management of Penile cancer in the United States: A population-based study.
    Bologna E; Licari LC; Franco A; Ditonno F; Manfredi C; De Nunzio C; Perdona S; Brassetti A; Leonardo C; Coogan CL; Cherullo EE; Autorino R
    Urol Oncol; 2024 Oct; 42(10):334.e11-334.e18. PubMed ID: 38944595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates in the molecular epidemiology and systemic approaches to penile cancer.
    Adashek JJ; Necchi A; Spiess PE
    Urol Oncol; 2019 Jul; 37(7):403-408. PubMed ID: 31053523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management and future perspectives of penile cancer: An updated review.
    Peyraud F; Allenet C; Gross-Goupil M; Domblides C; Lefort F; Daste A; Yacoub M; Haaser T; Ferretti L; Robert G; Ravaud A
    Cancer Treat Rev; 2020 Nov; 90():102087. PubMed ID: 32799062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dacomitinib in lung cancer: a "lost generation" EGFR tyrosine-kinase inhibitor from a bygone era?
    Ou SH; Soo RA
    Drug Des Devel Ther; 2015; 9():5641-53. PubMed ID: 26508839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear loss and cytoplasmic expression of androgen receptor in penile carcinomas: role as a driver event and as a prognosis factor.
    Kuasne H; Barros-Filho MC; Marchi FA; Drigo SA; Scapulatempo-Neto C; Faria EF; Rogatto SR
    Virchows Arch; 2018 Nov; 473(5):607-614. PubMed ID: 30099587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Expression Profiling of Advanced Penile Squamous Cell Carcinoma Receiving Cisplatin-based Chemotherapy Improves Prognostication and Identifies Potential Therapeutic Targets.
    Necchi A; Eigl BJ; Yang ES; Bae S; Chandrashekar D; Chen D; Naik G; Mehta A; Giannatempo P; Colecchia M; Gordetsky J; Wei S; Cooper T; Varambally S; Sonpavde G
    Eur Urol Focus; 2018 Sep; 4(5):733-736. PubMed ID: 28753783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The landscape of penile cancer research in Germany and Austria: a survey among professors in academic centers holding chair positions and results of a literature search.
    Sarcan S; Wolff I; Lusuardi L; Kravchuk A; Wiegland J; Yakac A; Thomas C; Burger M; Gilfrich C; Lebentrau S; Ahyai S; Merseburger A; May M
    World J Urol; 2024 Jan; 42(1):12. PubMed ID: 38189947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Pan-HER and ALK/ROS1/MET Inhibition with Dacomitinib and Crizotinib in Advanced Non-Small Cell Lung Cancer: Results of a Phase I Study.
    Jänne PA; Shaw AT; Camidge DR; Giaccone G; Shreeve SM; Tang Y; Goldberg Z; Martini JF; Xu H; James LP; Solomon BJ
    J Thorac Oncol; 2016 May; 11(5):737-747. PubMed ID: 26899759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial.
    Jänne PA; Ou SI; Kim DW; Oxnard GR; Martins R; Kris MG; Dunphy F; Nishio M; O'Connell J; Paweletz C; Taylor I; Zhang H; Goldberg Z; Mok T
    Lancet Oncol; 2014 Dec; 15(13):1433-1441. PubMed ID: 25456362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centralizing Penile Cancer Care in Germany and Austria: Just a Dream or a Fast-Approaching Reality? Results of a Survey Study among Urological Department Chairs and Modeling of Real Treatment Numbers of Penile Cancer Patients.
    Yakac A; Lebentrau S; Lusuardi L; Sarcan S; Burger M; Merseburger AS; Wiegland J; Gilfrich C; Wolff I; Ahyai S; May M; Thomas C
    Urol Int; 2023; 107(10-12):916-923. PubMed ID: 37918360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches.
    Udager AM; Liu TY; Skala SL; Magers MJ; McDaniel AS; Spratt DE; Feng FY; Siddiqui J; Cao X; Fields KL; Morgan TM; Palapattu GS; Weizer AZ; Chinnaiyan AM; Alva A; Montgomery JS; Tomlins SA; Jiang H; Mehra R
    Ann Oncol; 2016 Sep; 27(9):1706-12. PubMed ID: 27217541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.